Hims & Hers Health Launches Low Testosterone Treatments on Telehealth Platform

Sep 10, 2025

Hims & Hers Health announced the launch of new treatments for low testosterone through its telehealth platform. The company is expanding into this area to address a common health issue among men in the United States.

The new offerings include personalized and affordable treatment plans, including a branded oral testosterone medication. An estimated twenty million men in the U.S. are affected by low testosterone, which can contribute to reduced energy, lower mood and sexual desire, and increased health risks like heart disease and diabetes if left untreated.

With these new services, Hims & Hers Health aims to make it easier for men to access care for low testosterone and overcome the stigma that sometimes surrounds this health concern. The launch led to a rise in Hims & Hers Health's stock price following the announcement.

What is low testosterone?

Low testosterone is a medical condition where the body does not produce enough of the hormone testosterone, which can lead to symptoms such as low energy, poor mood, reduced sexual desire, and health complications.

How can Hims & Hers help men with low testosterone?

Hims & Hers now offers telehealth consultations and personalized treatment plans, making it easier for men to get help and treatment for low testosterone without visiting a clinic in person.

Why is this launch important for Hims & Hers?

The launch allows Hims & Hers to address a widespread health issue and expand its services, which may benefit both customers and the company's business.

Sources
Hims & Hers Health Expands Testosterone Offerings
WSJ
Hims & Hers Health is launching treatments for low testosterone on its telehealth platform, venturing deeper into a category often marred by stigma, according to its chief executive.
Hims Launches New Category in Men's Health with Exclusive Branded Oral Testoster...
Business Wire
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new category in men's health, offering access to innovative, affordable, and personalized treatment plans for low testosterone. An estimated twenty million...
Hims & Hers launches treatment plans for low testosterone
Reuters
Hims & Hers Health said on Wednesday it is launching a new category in men's health, offering access to personalized treatment plans for low testosterone.
Hims & Hers Bets On Hormonal Health To Revive Investor Confidence
Benzinga
Hims & Hers Health Inc. HIMS launched a new category in men's health on Wednesday, offering access to affordable and personalized treatment plans for low testosterone.
Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone
Investors Business Daily
Hims stock popped Wednesday after the telemedicine giant announced its long-awaited foray into offering testosterone replacement therapy.
Hims & Hers Looks Like Hyper Growth At A Reasonable Price
Seeking Alpha
Hims is now a GARP stock, combining rapid revenue and subscriber growth with a lower, fair valuation after a recent selloff. The company's scalable model, product launches, and global expansion plans support management's ambitious 2030 revenue and EBITDA targets. The stock trades at a reasonable his...
Show All Sources
Related Posts
Other News
Back to Top